Laura M Kenny

Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer

Graham E Searle, Mickael Huiban, Azeem Saleem, 2015, EJNMMI Research.

18F-ICMT-11, a Caspase-3–Specific PET Tracer for Apoptosis: Biodistribution and Radiation Dosimetry

Giampaolo Tomasi, G. Tomasi, E. Aboagye, 2013, The Journal of Nuclear Medicine.

Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods.

S. Shousha, S. Luthra, S. Osman, 2005, Cancer research.

Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography

S. Shousha, J. Stebbing, E. Aboagye, 2009, Clinical Cancer Research.

Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data

Lula Rosso, Federico E Turkheimer, F. Turkheimer, 2012, EJNMMI Research.

Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients

Matthias Glaser, R Charles Coombes, A. Hui, 2008, Journal of Nuclear Medicine.

Reproducibility of 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Tumor Volume Measurements

Dimitris Visvikis, Mathieu Hatt, Lula Rosso, 2010, The Journal of Nuclear Medicine.